Drugstore giant CVS Health had a rough ride in 2024, but things are rosier this year. CVS stock began forming a long cup base in January 2024 and dropped to a 43.56 low at the bottom of the cup, on Dec. 23.
Then it started getting healthier. CVS traded around 67 Wednesday afternoon, having soared 54% just since December. Additionally, CVS earned a positive adjustment to its Relative Strength (RS) Rating, from 89 to 92 Wednesday. The upgrade means that CVS stock is among the top 8% of all stocks, regardless of industry
Looking For The Best Stocks To Buy And Watch? Start Here
CVS Health is trying to complete a cup without handle with an 83.25 entry. See if it can clear the breakout price in heavy trade.
While revenue growth fell last quarter from 6% to 4%, EPS grew -44%, up from -51% in the previous report.
CVS Health earns the No. 6 rank among its peers in the 14-stock Medical-Managed Care industry group. Cigna Group, Alignment Healthcare and UnitedHealth Group are among the top 5 highly rated stocks within the group.
Th exclusive Relative Strength Rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks stacks up against all the other stocks in our database. Market research reveals that the best stocks often have an 80 or higher RS Rating as they launch their biggest price moves.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
